MedTrace Logo

Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy

NCT04090333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-02-05

No results posted yet for this study

Summary

The project will be conducted to investigate the hormonal homeostasis in men and women, with a special emphasis on sex hormones in men and AMH level in women, before and after withdrawal of the overused analgesics among MOH patients. Additionally, a more broad endocrine profile will be explored before and after withdrawal.

It is hypothesized that patients with MOH have disturbed hormone levels, which is normalized after withdrawal of the medication-overuse.

Conditions

  • Endocrine Disorder
  • Deficiency
  • Medication Overuse Headache
  • Migraine

Interventions

OTHER

Standard withdrawal therapy

All painkillers are abruptly stopped for a 2 months period.

Sponsors & Collaborators

  • Fertility Department, Rigshospitalet, Denmark

    collaborator UNKNOWN

  • Danish Headache Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2020-09-01
Completion
2020-10-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04090333 on ClinicalTrials.gov